佐剂
免疫疗法
医学
甘草
癌症研究
脂质体
癌症疫苗
癌症免疫疗法
免疫
淋巴
疫苗佐剂
不利影响
细胞免疫
肿瘤细胞
接种疫苗
癌症
细胞凋亡
免疫系统
疫苗疗法
免疫增强剂
免疫学
单克隆抗体
细胞
辅助治疗
药理学
作者
Xiaopan Yao,Keqing Zhang,Xiao-kun Zhang,Shengxin Lu,Jinyuan Hu,Yuexuan Wang,Jiayi Lin,Ye Wu,Weidong Zhang,Hongzhuan Chen,Xia Liu,Bei Wang,Xin Luan
标识
DOI:10.1186/s13046-025-03601-6
摘要
BACKGROUND: A key challenge in cancer immunotherapy is that tumor vaccines formulated with conventional aluminum adjuvants often fail to elicit potent cellular immunity and sustained antitumor responses. Glycyrrhizae polysaccharides (NGUP), characterized by significant immunomodulation, multi-target antitumor efficacy, and low toxicity, represent promising candidates for next-generation vaccine adjuvants. METHODS: We employed transcriptome analysis, quantitative real-time PCR, and Western blot assays to investigate the mechanism of NGUP in activating bone marrow-derived dendritic cells in vitro. Using confocal microscopy, small animal in vivo imaging, and flow cytometry, we examined the process of tumor antigen-specific T cell response activation by the liposomal vaccine (NGUPL@OVA) in vivo. The efficacy of NGUPL@OVA was evaluated in murine melanoma models (B16-OVA and B16-F10) through immunohistochemistry, immunofluorescence and H&E staining. RESULTS: T cell activation and inducing potent cellular immune responses with long-term immunological memory. In both prophylactic and therapeutic settings, NGUPL@OVA exhibits significant melanoma growth inhibition without observable toxic side effects. CONCLUSIONS: NGUP as a novel vaccine adjuvant for cancer immunotherapy effectively overcomes key limitations of conventional aluminum adjuvants, including weak induction of cell-mediated immunity and significant adverse effects, while exhibiting superior immune-stimulating properties.
科研通智能强力驱动
Strongly Powered by AbleSci AI